JP2005539011A5 - - Google Patents

Download PDF

Info

Publication number
JP2005539011A5
JP2005539011A5 JP2004526242A JP2004526242A JP2005539011A5 JP 2005539011 A5 JP2005539011 A5 JP 2005539011A5 JP 2004526242 A JP2004526242 A JP 2004526242A JP 2004526242 A JP2004526242 A JP 2004526242A JP 2005539011 A5 JP2005539011 A5 JP 2005539011A5
Authority
JP
Japan
Prior art keywords
compound
porphyrin
compound according
group
chemotherapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004526242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005539011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/023898 external-priority patent/WO2004012774A1/en
Publication of JP2005539011A publication Critical patent/JP2005539011A/ja
Publication of JP2005539011A5 publication Critical patent/JP2005539011A5/ja
Pending legal-status Critical Current

Links

JP2004526242A 2002-08-02 2003-07-30 ポルフィリン化合物と化学療法剤との結合体 Pending JP2005539011A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40051202P 2002-08-02 2002-08-02
PCT/US2003/023898 WO2004012774A1 (en) 2002-08-02 2003-07-30 Conjugates of porphyrin compounds with chemotherapeutic agents

Publications (2)

Publication Number Publication Date
JP2005539011A JP2005539011A (ja) 2005-12-22
JP2005539011A5 true JP2005539011A5 (enExample) 2006-08-31

Family

ID=31495832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004526242A Pending JP2005539011A (ja) 2002-08-02 2003-07-30 ポルフィリン化合物と化学療法剤との結合体

Country Status (7)

Country Link
US (1) US20040192665A1 (enExample)
EP (1) EP1525001A1 (enExample)
JP (1) JP2005539011A (enExample)
AU (1) AU2003257055A1 (enExample)
CA (1) CA2494214A1 (enExample)
MX (1) MXPA05001222A (enExample)
WO (1) WO2004012774A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066587A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Polyamines and their use in therapy
WO2002091989A2 (en) 2000-11-08 2002-11-21 Slil Biomedical Corporation Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
EP1515973A1 (en) * 2002-06-26 2005-03-23 Cellgate Inc. Porphyrin-polyamine conjugates for cancer therapy
FR2867189A1 (fr) * 2004-03-08 2005-09-09 Ludovic Bourre Nouveaux composes medicamenteux destines au traitement des pathologies dependantes de l'activite proteine kinase
CA2573927A1 (en) 2004-07-15 2006-01-19 The University Of Sydney Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis
EP2599497A3 (en) * 2008-09-08 2013-09-25 Hoffman/Barrett, L.L.C. Porphyrazine-chemotherapeutic agents conjugates
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
PT3149025T (pt) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
CA3028122A1 (en) 2016-06-16 2017-12-21 Oncoselect Therapeutics, Llc Porphyrin compounds and compositions useful for treating cancer
EP3638248A4 (en) 2017-06-16 2021-06-30 The Regents of The University of California CONJUGATES OF PHARMACEUTICAL INGREDIENTS
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
EP3746105A4 (en) 2018-01-29 2022-05-18 Ohio State Innovation Foundation CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
CN108409756B (zh) * 2018-03-08 2019-12-10 莎穆(上海)生物科技有限公司 一种基于喜树碱类的异二聚体多功能前药及其制备方法和应用
CN119504769B (zh) * 2024-10-21 2025-09-30 高博药业有限公司 一种靶向her2的抗体偶联金（ⅲ）卟啉药物及其合成与肿瘤治疗应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435087A1 (de) * 1994-09-30 1996-04-04 Deutsches Krebsforsch Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
FR2764605B1 (fr) * 1997-06-17 2004-03-26 Univ Hyderabad Molecules hybrides d'un photosensibilisateur et d'un agent chimiotherapeutique, leur procede de production et leur application collaterale en chimiotherapie et therapie photodynamique
US5889061A (en) * 1997-10-15 1999-03-30 Wisconsin Alumni Research Foundation Conformationally restricted polyamines
US20020155999A1 (en) * 1998-04-30 2002-10-24 Han In Suk Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
CA2334809A1 (en) * 1998-06-05 1999-12-09 Board Of Regents, The University Of Texas System Texaphyrin conjugates and uses thereof
DE19831217A1 (de) * 1998-07-03 2000-01-05 Schering Ag Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
WO2001028592A1 (en) * 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Cobalamin conjugates useful as imaging agents and as antitumor agents
WO2002096417A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
EP1515973A1 (en) * 2002-06-26 2005-03-23 Cellgate Inc. Porphyrin-polyamine conjugates for cancer therapy

Similar Documents

Publication Publication Date Title
Blanco et al. Rotaxanes as new architectures for photoinduced electron transfer and molecular motions
JP2011505386A5 (enExample)
RU95112842A (ru) Противоопухолевая композиция, содержащая производные таксана
CN1313145C (zh) 青蒿素相关性内过氧化物与携带铁的蛋白质之间的共价缀合物及其使用方法
JP2009521515A (ja) 腫瘍細胞における耐性を克服するためのタンパク質ベースの担体システム
KR102187410B1 (ko) 치료제를 전달하기 위한 pH-민감성 링커
Murakami et al. Enantioselective discrimination by cage-type cyclophanes bearing chiral binding sites in aqueous media
ES2707228T3 (es) Nuevo método y aplicación de porfirinas y clorinas asimétricamente meso-sustituidas para TFD
JP2023504286A5 (enExample)
EP1215199A1 (en) Linker molecules for selective metallisation of nucleic acids and their uses
JP2012502052A5 (enExample)
RU2010101052A (ru) Производные бициклоанилина
JP2020518660A (ja) Ｒａｆ分解性結合体化合物
Dröge et al. A dinuclear osmium (II) complex near-infrared nanoscopy probe for nuclear DNA
ECSP055618A (es) Terapia de combinacion para enfermedades hiperproliferativas
JP2009544727A5 (enExample)
ZA200501854B (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors.
JP2022502463A (ja) 官能化シクロオクテンを調製するためのプロセス
US20130210756A1 (en) PHEOPHORBIDE-alpha CONJUGATES AND THEIR USES
JP2012518598A5 (enExample)
Lindenbaum A survey of naturally occurring chelating ligands
CA2432792A1 (en) Methods for modulating tumor growth and metastasis
JP2005539011A (ja) ポルフィリン化合物と化学療法剤との結合体
AU2002221622B2 (en) Antitumor therapy comprising distamycin derivatives
EP4522139A1 (en) Radiation cleaved drug-conjugate linkers enable local payload release sclerosis